Plus: Biotia validates AI-powered UTI test, Flora raises ¥230 million, and menopause symptoms reduce sexual satisfaction.
Oura will launch two new features globally on May 6, significantly expanding its offerings in hormonal health for femtech operators. This move arrives as new research links menopausal symptoms to reduced sexual satisfaction, highlighting an industry-wide need for more comprehensive support for women across their reproductive lifespans. Stakeholders are responding with solutions: one company unveiled an AI-powered UTI test to address diagnostic gaps, while another raised ¥230 million to scale its women's health platform. Five takes inside, plus a quick-hits roundup.
VIA FemTech Insider
Kyoto-based femtech startup Flora raised approximately ¥230 million (~$1.5 million) from Ritsumeikan Social Impact Fund, Nagase Future Fund, and PE&HR. This brings Flora's total funding to date to approximately ¥500 million (~$3.3 million). Flora uses AI to address the gender data gap in healthcare.
Read the full story →
— The Luteal Editorial Team
VIA FemTech Insider
Oura is launching two new features globally on May 6: Hormonal birth control support within Cycle Insights and a Menopause Insights experience. These updates, built around a proprietary clinical questionnaire, mark Oura's most significant expansion into hormonal health. The hormonal birth control feature adapts Cycle Insights for users of various hormonal methods.
Read the full story →
— The Luteal Editorial Team
VIA FemTech Insider
Biotia published a clinical validation study in Microbiology Spectrum for its next-generation sequencing and machine learning-based urinary tract infection test. The BIOTIA-ID Urine Test achieved 97.2% sensitivity and 99.6% specificity across 1,470 clinical specimens, addressing a diagnostic gap where standard culture-based testing often misses organisms.
Read the full story →
— The Luteal Editorial Team
VIA Contemporary OB/GYN
A study of 1206 women found that more menopausal symptoms correlated with decreased sexual satisfaction. This occurred even though many of these women remained sexually active as they aged.
Read the full story →
— The Luteal Editorial Team
VIA Contemporary OB/GYN
Half of patients report dissatisfaction with their sexual health. Clinicians should normalize sexual health concerns by asking simple, open-ended questions.
Read the full story →
— The Luteal Editorial Team
